Jenkem Technology Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary, Public
- Established
- 2001-10-09
- Employees
- 298
- Market Cap
- -
- Website
- http://www.jenkem.com
JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
Phase 2
Recruiting
- Conditions
- Glioblastoma Multiforme (GBM)
- Interventions
- Drug: JK-1201IDrug: Temozolomide (TMZ)
- First Posted Date
- 2024-09-13
- Last Posted Date
- 2024-09-13
- Lead Sponsor
- JenKem Technology Co., Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT06595186
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Beijing, China
JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases
Phase 2
Not yet recruiting
- Conditions
- Triple Negative Breast Cancer (TNBC)Brain Metastasases
- Interventions
- Drug: JK-1201I
- First Posted Date
- 2024-09-06
- Last Posted Date
- 2024-09-06
- Lead Sponsor
- JenKem Technology Co., Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT06586866
JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer
Phase 3
Not yet recruiting
- Conditions
- Small Cell Lung Cancer
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2024-09-03
- Lead Sponsor
- JenKem Technology Co., Ltd.
- Target Recruit Count
- 394
- Registration Number
- NCT06581380
Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC
Phase 1
- Conditions
- Small Cell Lung Cancer (SCLC)
- Interventions
- Drug: JK-1201I
- First Posted Date
- 2021-12-15
- Last Posted Date
- 2022-01-05
- Lead Sponsor
- JenKem Technology Co., Ltd.
- Target Recruit Count
- 63
- Registration Number
- NCT05158491
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China
Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan in Patients With Malignant Solid Tumor
Phase 1
Completed
- Conditions
- Solid Tumor
- First Posted Date
- 2020-04-29
- Last Posted Date
- 2021-11-17
- Lead Sponsor
- JenKem Technology Co., Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT04366648
© Copyright 2025. All Rights Reserved by MedPath